Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul McLaughlin

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Addiction (Abingdon, England)|August 22, 2013
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trialYih-Ing Hser, Andrew J Saxon, David Huang, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 13, 2026
Normalization of Haemostasis in People with Haemophilia A: Expert Consensus on Unmet Needs and a Framework for Advancing Towards Health EquityCedric Hermans, Günter Auerswald, Ruben Berrueco, et al.
Journal of Substance Abuse Treatment|March 24, 2010
From research to the real world: buprenorphine in the decade of the Clinical Trials NetworkWalter Ling, Petra Jacobs, Maureen Hillhouse, et al.
Journal of Psychoactive Drugs|November 4, 2014
Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) studyCheryl Teruya, Robert P Schwartz, Shannon Gwin Mitchell, et al.
Addiction (Abingdon, England)|November 25, 2015
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trialYih-Ing Hser, Elizabeth Evans, David Huang, et al.
Drug and Alcohol Dependence|August 28, 2012
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trialAndrew J Saxon, Walter Ling, Maureen Hillhouse, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2024
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panelMike Laffan, Paul McLaughlin, Jayashree Motwani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network TrialSusan Tross, Aimee N C Campbell, Lisa R Cohen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2024
A clinical practice guideline for primary care physiotherapy in patients with haemophiliaJohan Blokzijl, Martijn F Pisters, Magnus Aspdahl, et al.
Research and Practice in Thrombosis and Haemostasis|March 31, 2022
The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international studyJean St-Louis, Audrey Abad, Sharon Funk, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Addiction (Abingdon, England)|August 22, 2013
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trialYih-Ing Hser, Andrew J Saxon, David Huang, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 13, 2026
Normalization of Haemostasis in People with Haemophilia A: Expert Consensus on Unmet Needs and a Framework for Advancing Towards Health EquityCedric Hermans, Günter Auerswald, Ruben Berrueco, et al.
Journal of Substance Abuse Treatment|March 24, 2010
From research to the real world: buprenorphine in the decade of the Clinical Trials NetworkWalter Ling, Petra Jacobs, Maureen Hillhouse, et al.
Journal of Psychoactive Drugs|November 4, 2014
Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) studyCheryl Teruya, Robert P Schwartz, Shannon Gwin Mitchell, et al.
Addiction (Abingdon, England)|November 25, 2015
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trialYih-Ing Hser, Elizabeth Evans, David Huang, et al.
Drug and Alcohol Dependence|August 28, 2012
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trialAndrew J Saxon, Walter Ling, Maureen Hillhouse, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2024
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panelMike Laffan, Paul McLaughlin, Jayashree Motwani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network TrialSusan Tross, Aimee N C Campbell, Lisa R Cohen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2024
A clinical practice guideline for primary care physiotherapy in patients with haemophiliaJohan Blokzijl, Martijn F Pisters, Magnus Aspdahl, et al.
Research and Practice in Thrombosis and Haemostasis|March 31, 2022
The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international studyJean St-Louis, Audrey Abad, Sharon Funk, et al.
Pageof 5